Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIE: Panitumumab, Irinotecan, and Everolimus in mCRC
NCT01139138Phase 2Completed
- Start
- Jun 2010
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in metastatic colorectal cancer (mCRC). Started Jun 2010; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01139138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01139138.